IDEXX Laboratories Inc (IDXX) Common Stock USD0.10

Sell:$545.74Buy:$546.13Price decreased$25.72 (4.49%)

NASDAQ:Price decreased1.35%
Market closed |
Prices delayed by at least 15 minutes
Sell:$545.74
Buy:$546.13
Change:Price decreased$25.72 (4.49%)
Market closed |
Prices delayed by at least 15 minutes
Sell:$545.74
Buy:$546.13
Change:Price decreased$25.72 (4.49%)
Market closed |
Prices delayed by at least 15 minutes

Company Information

About this company

IDEXX Laboratories, Inc. develops, manufactures, and distributes products and provides services primarily for the companion animal veterinary; livestock, poultry and dairy; and water testing industries. It also manufactures and sells human medical point-of-care diagnostic products. Its products and services include point-of-care veterinary diagnostic products, comprised of instruments, consumables, and rapid assay test kits. It also includes veterinary reference laboratory diagnostic and consulting services. It offers practice management systems, software and diagnostic imaging systems and services used by veterinarians. It also offers health monitoring, biological materials testing, laboratory diagnostic instruments, and services used by the biomedical research community. The Company provides diagnostic and health-monitoring products for livestock, poultry, and dairy; and products that test water for certain microbiological contaminants.

Key people

Jonathan Mazelsky
Executive Chairman of the Board
Lawrence D. Kingsley
Lead Independent Director
Irene Chang Britt
Independent Director
Bruce L. Claflin
Independent Director
Stuart M. Essig
Independent Director
Joseph L. Hooley
Independent Director
Michael G. Erickson
President, Chief Executive Officer, Director
Andrew Emerson
Executive Vice President, Chief Executive Officer, Treasurer
Michael P. Johnson
Chief Human Resources Officer, Executive Vice President
Martin Smith
Executive Vice President and Chief Technology Officer, R&D, Global Operations, Information Technology and Information Security
Sharon E. Underberg
Executive Vice President, General Counsel, Corporate Secretary
Michael J. Lane
Executive Vice President and General Manager - CAG Diagnostics Business Unit
Michael Schreck
Executive Vice President and General Manager - Veterinary Software, Diagnostic Imaging and Telemedicine, Corporate Accounts and Customer Experience
George J. Fennell
Executive Vice President - Global CAG Commercial
Click to see more

Key facts

  • Shares in issue
    108.14m
  • EPIC
    IDXX
  • ISIN
    US45168D1046
  • Location
    United States
  • Sector
    Consumer/Non-Cyclical
  • Industry
    Fish/Livestock
  • Market cap
    $44.96bn
  • Employees
    11,000
  • Exchange
    NASDAQ
  • Index
    S&P 500, NASDAQ 100 Index, TR Equity United States Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.